Navigation Links
Intelligent Medical Devices, Inc. (IMDx) Introduces a CE-Marked Automated Assay for the Detection of C. difficile Including Hypervirulent Strains
Date:8/1/2011

CAMBRIDGE, Mass., Aug. 1, 2011 /PRNewswire/ -- Intelligent Medical Devices, Inc. (IMDx) today announced it has received CE-Mark for a high-throughput automated assay for the detection of C. difficile, including the A-B+ 1470 variant, as well as the NAP1 strain. The IMDx™ C. difficile assay for the Abbott m2000™ is the first assay released under a multi-year distribution agreement between Abbott and IMDx whereby IMDx will design, develop, regulatory clear, and manufacture assays for the Abbott FDA cleared m2000 instrument.

Designed utilizing IMDx's proprietary bioinformatics process, the IMDx C. difficile assay for the Abbott m2000 demonstrates a sensitivity of 95.7 percent and a specificity of 100 percent (internal comparison data).  C. difficile may develop after prolonged antibiotic use and is the most frequent cause of health-care-associated diarrhea, also causing more severe intestinal conditions such as colitis. The bacterium is easily transmitted via direct contact with high-touch surfaces in patient rooms, contaminated patient-care items, and hands of health-care workers.

"Our assays are developed to incorporate evolving clinical needs. Not only do we offer automated detection of toxigenic C. difficile genes, shortening the time needed to diagnose infections, but we also cover the detection of hypervirulent strains, including NAP1, and tcdB-variant strains, including 1470.  Early identification of pathogens is critical in improving patient healthcare, shortening hospital stays, and reducing expenses," says Alice Jacobs, MD, Chairman & CEO of IMDx.

About IMDx

Based in Cambridge, MA, IMDx (www.IntelligentMDx.com) is an innovative company that designs, develops and manufactures molecular diagnostic products. IMDx has developed molecular solutions that are clinically impactful and competitiv
'/>"/>

SOURCE Intelligent Medical Devices, Inc. (IMDx)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
2. Verification Studies of IntelligentMDxs Proprietary Molecular Diagnostic Assay Process Have Been Completed
3. Frost & Sullivan Recognizes IntelligentMDx for Its Commitment to the Advancement of Healthcare and Diagnostics
4. Zargis Cardioscan The Intelligent Stethoscope Now Available on Amazon.com
5. Usability Sciences Corporation Launches WebIQ Pharma - An Intelligent Survey Tool That Allows Pharma Sites to Measure and Improve Website Effectiveness
6. Elekta to Highlight Intelligent Cancer Management Solutions at 2010 AAPM Annual Meeting
7. Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests
8. Finesse Launches RemoteView OPC and BatchReport Modules for Intelligent Harmonization of Third Party Bioreactor Controllers and Analyzers with TruBio DV 4.0 Bioprocess Software
9. Precyse Announces Commercial Release of Revolutionary Intelligent Workflow Solution for Health Information Management
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... , Spanien, September 23, 2014 ... dass sich Fernzugriffe auf eTMF im Jahr ... ermöglicht den Sponsoren von klinischen Versuchsreihen, die ... und Vollständigkeit von Stammdateien mit Informationen über ... zu erfüllen     Die bisher ...
(Date:9/22/2014)... 22, 2014 Levi & Korsinsky is investigating ... "the Company") (NasdaqGS: SIAL ) for possible ... law in connection with the sale of the Company ... to learn more about the investigation: http://zlkdocs.com/SIAL-Info-Request-Form_ma-2199 , ... to you. Under the terms of the ...
(Date:9/22/2014)... , Sept. 22, 2014 Avanir Pharmaceuticals, ... it is offering to sell $200 million of its ... Deutsche Bank Securities and BofA Merrill Lynch are acting ... grant the underwriters a 30-day option to purchase additional ... to be sold in the offering are being sold ...
Breaking Medicine Technology:Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 2Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 3Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 4Branchenweite Umfrage zeigt, dass sich Fernzugriffe auf eTMF im Jahr 2015 verdoppeln werden 5SIGMA-ALDRICH INVESTOR ALERT: Levi & Korsinsky, LLP Investigates the Board of Directors of Sigma-Aldrich Corporation In Connection with the Sale of the Company to Merck -- SIAL 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Avanir Pharmaceuticals Announces Proposed Public Offering of Common Stock 3
... S.C., Sept. 9 At approximately 3:21,PM ... Chairman and Founder of,CureHIV.us, agreed to act ... Global,Humanceuticals, Inc,s., new extremely effective, safe and ... non-government, U.S.,and foreign institutions, organizations, and corporations, ...
... Effective Antibiotics Against ,Superbugs, BOSTON, Sept. 6 ... may have discovered the path,toward developing better drugs ... resistance to common antibiotics. The,researchers have discovered a ... opens to door to new avenues of research., ...
Cached Medicine Technology:Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 2Boston University Biomedical Engineers Find Chink in Bacteria's Armor 3
(Date:9/22/2014)... September 23, 2014 Career Step, ... training, will be attending and exhibiting at the ... Health Information Management Association (AHIMA) in San Diego, ... through October 1, and Career Step will be ... suite of coding training products, including CLiM™, its ...
(Date:9/22/2014)... Fashion Footwear Association of New York (FFANY) and leading ... research to the University of Pittsburgh Cancer Institute (UPCI), ... the proceeds of the 20th annual QVC Presents "FFANY ... several cancer research centers across the country, including UPCI ... has been selected to receive funds from this year,s ...
(Date:9/22/2014)... New York, NY (PRWEB) September 22, 2014 ... Women’s Radio Network launched their first evening show, “KC After ... and Marcus Edwards, “KC After Dark” will air every Tuesday ... away a free iPad for the 50th caller, and because ... it well past the call in mark with 500 callers. ...
(Date:9/22/2014)... 2014 United States District Judge ... federal mesh lawsuits ( http://www.meshinjurylawfirm.com/lawsuits/ ) filed against ... for pretrial matters, issued an order in the ... System Products Liability Litigation (United States District Court ... no. 2:12-md-02326)—requiring that four member cases be ready ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Locating the ... industry is now easier using the Quotes Pros portal ... trying to local universal life insurance pricing from different ... coverage plans that are easily viewed when using the ... specific lengths of coverage. The plan data can be ...
Breaking Medicine News(10 mins):Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Heels for a cause: FFANY, QVC Present $240,000 from shoe sales to Pitt researchers 2Health News:The Women’s Radio Network, WRNW1’s First Evening Show a Huge Success 2Health News:Federal Court Sets Trial Date for Boston Scientific Vaginal Mesh Cases in Florida, the Rottenstein Law Group LLP Reports 2Health News:Universal Life Insurance Prices for Adults Added to National Insurer Portal Online 2
... 27 April 2009 Elsevier, the world-leading publisher ... services, is pleased to announce the launch of ... the journal on infectious disease dynamics ( http://www.elsevier.com/locate/epidemics ... papers on infectious disease dynamics in the broadest ...
... global partner and customer pilots in Europe and Asia ... Live - Booth #333- With deployments of its PLUS ... and healthcare installations in the United States, and pilots ... , a leader in precision UWB real-time location ...
... hormone-lowering therapy may require close monitoring, researchers say, ... proven effective, treating prostate cancer with the testosterone-lowering ... men,s risk for developing bone fractures and fatal ... likelihood of developing either side effect remains low, ...
... BELLEVUE, Wash., April 27 HIPAApedia.com, the first ... IT community and business professionals interested in HIPAA ... Sponsored by Edifecs, the leader in providing healthcare ... provides an online environment for collaborative, transparent, and ...
... Unique Software Application Suite for the Assessment of the ... providing state-of-the-art CT and MR imaging systems to physician ... American Urological Association that the U.S. Food and Drug ... unique software application package for the assessment of urinary ...
... today announced financial and operating results for its first quarter ended ... Quarter Summary:, , ... Net income attributable to HCA Inc. ... first quarter. , Adjusted EBITDA ...
Cached Medicine News:Health News:Elsevier launches Epidemics -- the journal on infectious disease dynamics 2Health News:Time Domain Goes Global, Announces Worldwide Availability of its PLUS(TM) Ultra Wideband Real-Time Location System Sensor Platform 2Health News:Time Domain Goes Global, Announces Worldwide Availability of its PLUS(TM) Ultra Wideband Real-Time Location System Sensor Platform 3Health News:Time Domain Goes Global, Announces Worldwide Availability of its PLUS(TM) Ultra Wideband Real-Time Location System Sensor Platform 4Health News:Heart, Bone Problems May Follow Prostate Cancer Treatment 2Health News:Heart, Bone Problems May Follow Prostate Cancer Treatment 3Health News:HIPAApedia.com Goes Live - The First Dedicated Educational Community Wiki Aimed at Healthcare Information Professionals Interested in HIPAA Regulatory Issues and Solutions. 2Health News:Neuisys Announces FDA Clearance of UroCARE 2Health News:HCA Reports First Quarter 2009 Results 2Health News:HCA Reports First Quarter 2009 Results 3Health News:HCA Reports First Quarter 2009 Results 4Health News:HCA Reports First Quarter 2009 Results 5Health News:HCA Reports First Quarter 2009 Results 6Health News:HCA Reports First Quarter 2009 Results 7Health News:HCA Reports First Quarter 2009 Results 8Health News:HCA Reports First Quarter 2009 Results 9Health News:HCA Reports First Quarter 2009 Results 10Health News:HCA Reports First Quarter 2009 Results 11Health News:HCA Reports First Quarter 2009 Results 12Health News:HCA Reports First Quarter 2009 Results 13Health News:HCA Reports First Quarter 2009 Results 14
Binocular indirect ophthalmic lenses. Small pupil diagnosis & treatment....
Binocular indirect ophthalmic lenses. Ultra-High resolutions viewing of posterior pole....
... Volk's super series slit ... resolution viewing of the ... fundus diagnostic capability, specifically ... of view, fundus image ...
Volk indirect lenses. General diagnosis & treatment....
Medicine Products: